cro.directory
← Compare landing

AAVATAR Therapeutics vs uBriGene

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAAVATAR TherapeuticsuBriGene
SummaryAAVATAR Therapeutics is an innovative gene therapy company developing a next-generation intelligent gene therapy platform.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Services
  • Discovery Research
  • Translational Research
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Analytical Method Development & Validation
  • Translational Research
Modalities
  • Gene Therapy
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
Phases
  • Discovery
  • Preclinical (General)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters, Seoul, Seoul, Republic of Korea
  • BRA, Seoul, Gangdong-gu, Republic of Korea
  • HQ, Hanam-si, Gyeonggi-do, Republic of Korea
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
CertificationsData not yet provided.
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted

Find similar companies

AAVATAR Therapeutics alternatives · uBriGene alternatives

Markdown mirror: /compare/en-aavatartps/ubrigene.md